Validating novel targets for pharmacological interventions in schizophrenia

Am J Psychiatry. 2009 Jul;166(7):753-6. doi: 10.1176/appi.ajp.2009.09040522.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antipsychotic Agents / pharmacology
  • Antipsychotic Agents / therapeutic use
  • Benzodiazepines / pharmacology
  • Benzodiazepines / therapeutic use
  • Drug Therapy / methods*
  • GTP-Binding Proteins / drug effects
  • GTP-Binding Proteins / metabolism
  • Humans
  • Olanzapine
  • Receptors, GABA / drug effects
  • Receptors, GABA / metabolism
  • Receptors, Glutamate / drug effects
  • Receptors, Glutamate / metabolism
  • Receptors, Metabotropic Glutamate / drug effects
  • Receptors, Metabotropic Glutamate / metabolism
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Reproducibility of Results
  • Schizophrenia / drug therapy*
  • Schizophrenia / metabolism
  • Schizophrenia / physiopathology

Substances

  • Antipsychotic Agents
  • Receptors, GABA
  • Receptors, Glutamate
  • Receptors, Metabotropic Glutamate
  • Receptors, N-Methyl-D-Aspartate
  • metabotropic glutamate receptor 2
  • metabotropic glutamate receptor 3
  • Benzodiazepines
  • GTP-Binding Proteins
  • Olanzapine